Guidelines for using NMDP slides

1
Guidelines for using NMDP slides

• The information and data in this presentation
  were prepared by the National Marrow Donor
  Program (NMDP). Each slide and/or information may
  be used in its entirety in presentations and
  publications as long as it is attributed to the
  National Marrow Donor Program.
• When used in presentations, NMDP slides should
  retain their content, appearance and design. (For
  instructions on copying the design along with the
  contents, see the notes to this slide.)
• Presentation notes are included to supplement the
  slide content. To print the notes, select Notes
  Pages in your printer window.
• To download the file to your computer, select
  Save As in the File menu.

2
Acute Lymphoblastic LeukemiaSurvival of Adult
(Age ³ 18 Years) Marrow Recipients with
Myeloablative Preparative Regimens, by Disease
Stage 19982006
Log-rank p-value lt 0.0001
First complete remission (n 195)
Second complete remission (n 179)
Advanced (n 218)
3
Acute Lymphoblastic LeukemiaSurvival of Adult
(Age ³ 18 Years) PBSC Recipients with
Myeloablative Preparative Regimens, by Disease
Stage 19982006
Log-rank p-value lt 0.0001
First complete remission (n 193)
Second complete remission (n 152)
Advanced (n 157)
4
Acute Lymphoblastic LeukemiaSurvival of
Pediatric (Age lt 18 Years) Marrow Recipients with
Myeloablative Preparative Regimens, by Disease
Stage 19982006
Log-rank p-value lt 0.0001
First complete remission (n 138)
Second complete remission (n 280)
Advanced (n 146)
5
Acute Myelogenous LeukemiaSurvival of Adult (Age
³ 18 Years) Marrow Recipients with Myeloablative
Preparative Regimens, by Disease Stage 19982006
Log-rank p-value lt 0.0001
Second complete remission (n 264)
First complete remission (n 274)
Advanced (n 479)
6
Acute Myelogenous LeukemiaSurvival of Adult (Age
³ 18 Years) PBSC Recipients with Myeloablative
Preparative Regimens, by Disease Stage 19982006
Log-rank p-value lt 0.0001
First complete remission (n 352)
Second complete remission (n 200)
Advanced (n 363)
7
Acute Myelogenous LeukemiaSurvival of Pediatric
(Age lt 18 Years) Marrow Recipients with
Myeloablative Preparative Regimens, by Disease
Stage 19982006
Log-rank p-value 0.0004
Second complete remission (n 137)
First complete remission (n 98)
Advanced (n 116)
8
Acute Myelogenous LeukemiaSurvival of Older
Adult (Age ³ 55 Years) Marrow and PBSC Recipients
with Non-Myeloablative Preparative Regimens, by
Disease Stage 19982006
Log-rank p-value 0.0002
Second complete remission (n 107)
First complete remission (n 239)
Advanced (n 113)
9
Acute Myelogenous LeukemiaSurvival of Older
Adult (Age ³ 55 Years) Marrow and PBSC Recipients
with Myeloablative Preparative Regimens, by
Disease Stage 19982006
Log-rank p-value 0.009
First complete remission (n 82)
Second complete remission (n 44)
Advanced (n 69)
10
Chronic Myelogenous LeukemiaSurvival of Adult
(Age ³ 18 Years) Marrow Recipients with
Myeloablative Preparative Regimens, by Disease
Stage 19982006
Log-rank p-value lt 0.0001
First chronic phase (n 695)
Second chronic phase / Accelerated phase (n
273)
Blast phase (n 45)
11
Chronic Myelogenous LeukemiaSurvival of Adult
(Age ³ 18 Years) PBSC Recipients with
Myeloablative Preparative Regimens, by Disease
Stage 19982006
Log-rank p-value 0.004
First chronic phase (n 105)
Second chronic phase / Accelerated phase (n
117)
Blast phase (n 28)
12
Inherited Immune SyndromesSurvival of Pediatric
(Age lt 18 Years) Marrow Recipients with All
Preparative Regimens, by Disease 19982006
WAS (n 48)
SCID (n 35)
13
Inherited Metabolic DisordersSurvival of
Pediatric (Age lt 18 Years) Marrow Recipients with
Myeloablative Preparative Regimens, by
Disease 19982006
Hurler (n 30)
ALD / MLD (n 29)
14
Myelodysplastic SyndromesSurvival of Adult (Age
³ 18 Years) Marrow Recipients with Myeloablative
Preparative Regimens, by FAB Disease
Classification 19982006
RA / RARS (n 77)
RAEB / RAEB-t (n 178)
15
Myelodysplastic SyndromesSurvival of Adult (Age
³ 18 Years) PBSC Recipients with Myeloablative
Preparative Regimens, by FAB Disease
Classification 19982006
RAEB / RAEB-t (n 127)
RA / RARS (n 73)
16
Myelodysplastic SyndromesSurvival of Adult (Age
³ 18 Years) Marrow and PBSC Recipients with All
Preparative Regimens, by Age at
Transplant 19982006
Log-rank p-value 0.03
Age 1854 Years (n 289)
Age ³ 55 Years (n 163)
17
Myelodysplastic SyndromesSurvival of Adult (Age
³ 18 Years) Marrow and PBSC Recipients by
Conditioning Regimen 19982006
Log-rank p-value 0.11
Myeloablative (n 305)
Non-myeloablative (n 147)
18
Non-Hodgkin LymphomaSurvival of Adult (Age ³ 18
Years) Transplant Recipients with
Non-Myeloablative Preparative Regimens, by
Product Type 19982006
Log-rank p-value 0.92
Marrow (n 138)
PBSC (n 254)
19
Severe Aplastic AnemiaSurvival of Marrow
Recipients with All Preparative
Regimens 19982006
Log-rank p-value 0.12
Age lt 18 Years (n 218)
Age ³ 18 Years (n 166)
20
Fanconi AnemiaSurvival of Pediatric (Age lt 18
Years) Marrow Recipients with Non-Myeloablative
Preparative Regimens 19982006
Fanconi anemia (n 64)